scholarly journals Vesicovaginal fistula and vesicocutaneous fistula in a patient having pelvic ectopic kidney with pyonephrosis: a unique therapeutic challenge

2018 ◽  
pp. bcr-2018-225331
Author(s):  
Siddharth Pandey ◽  
Ajay Aggarwal ◽  
Manoj Kumar ◽  
Satyanarayan Sankhwar
2007 ◽  
Vol 177 (4S) ◽  
pp. 289-289
Author(s):  
Michael E. Woods ◽  
Jeff Bejma ◽  
Rodney Davis

2017 ◽  
Author(s):  
Daniela Magalhaes ◽  
Cesar Esteves ◽  
Maria Manuel Costa ◽  
Pedro Rodrigues ◽  
Davide Carvalho

2018 ◽  
Author(s):  
Alexandra Mirica ◽  
Rodica Petris ◽  
Radu Mirica ◽  
Sorin Paun ◽  
Corin Badiu ◽  
...  

Author(s):  
Ujjwal Kumar ◽  
Krishnendra Varma ◽  
Shashank Bhargava

Author(s):  
Aylin Akbulut ◽  
Suleyman Kalayci ◽  
Gokhan Koca ◽  
Meliha Korkmaz

Background: Supernumerary kidney is an accessory organ with its own encapsulated parenchyma, blood vessels and ureters, either separated from the normal kidney or connected to it via fibrous tissue and ectopic kidney is a migration abnormality of the kidney. Here, we have evaluated a rare case of the supernumerary and ectopic kidney with DMSA, MAG3 and also CT fusion of the images. Methods: The absolute divided renal function was calculated for each kidney by DMSA. The MAG3 scintigraphy showed no obstruction in the ureteropelvic junction. Furthermore, the renogram curve and Tmax and time to ½ values were assessed. Two months after the conventional scintigraphies, the patient was referred to a CT scan and the fusion of DMSA SPECT and CT data was generated on a workstation. Results: The ectopic supernumerary kidney was functioning very well except a small hypoactive area, visible on DMSA, which was possibly a minimal pelvicalyceal dilatation. However, consequent CT scan did not show any pathology. Conclusion: It is important to evaluate particularly complicated or rare cases with multimodality systems with 3D or fusion techniques for the accurate diagnosis.


2020 ◽  
Vol 13 (5) ◽  
pp. e234490
Author(s):  
Evan C Chen ◽  
Jonathan A Stefely ◽  
Bimalangshu R Dey ◽  
Walter H Dzik

Haemophagocytic lymphohistiocytosis (HLH) can be a rapidly fatal disease. Current treatment in adults is extrapolated from the HLH-2004 protocol that specifies a regimen of etoposide, dexamethasone and cyclosporine. However, HLH presents as a spectrum of disease severity. A therapeutic challenge arises for milder cases where the harms of potent chemotherapy such as etoposide may outweigh its benefit. We present a case of an adult with HLH who developed significant pancytopenia but was otherwise not critically ill and who responded to treatment with a chemotherapy-sparing approach consisting of intravenous immunoglobulins and corticosteroids alone. The case illustrates that tailored therapy may allow effective treatment of the disorder while minimising therapy-related toxicities.


Sign in / Sign up

Export Citation Format

Share Document